We are pleased to partner with the largest and most successful plastic surgery provider in England, Scotland, Wales and Northern Ireland. As a long-time market leader in the UK, the group has over 30 state-of-the-art clinics and multiple hospitals and is responsible for thousands of successful operations each year. Transform & The Hospital Group have chosen Tomorrowlabs products to optimize the optical results of their treatments and to ensure ideal aftercare.
The results of a study by the Technical University of Munich prove the correlation between HSF treatment and sustainable skin rejuvenation and clearly show that HSF actively restores the biological regenerative processes that are impaired in aged skin. The study, presented by the medical researchers, was awarded the Presentation Prize for its contribution to the research in a pioneering area of regenerative medicine. We congratulate all participating scientists.
The B&C Private Foundation the largest private industrial holding in Austria, has been created to promote Austrian entrepreneurship. For this reason, the B & C Private Foundation created the Houska Award, endowed with a total of 400,000 euros, and 2018 awarded for the 13th time. The Houska Award honors outstanding business-related research achievements from Austrian companies. As an Austrian high-tech company Tomorrowlabs was happy to support this event as a sponsor.
Tomorrowlabs is pleased to announce the lecture "Skin Rejuvenation through HIF-alpha upregulation - a new treatment paradigm in anti-aging medicine" as part of the 9th International Conference on Regenerative Surgery on the 15th and 16th of December 2017 in Rome, as well as two other lectures at the 8th Bozner Symposium of Plastic Surgery from 26 to 28 January 2018. These opportunities will be used to present background data on our patented mechanism of action as well as the first results of our research in the area of minimally invasive facial rejuvenation by means of threadlifting.
We are proud to announce that the scientific article "Skin rejuvenation through HIF-alpha modulation" has been accepted for publication in the world's best jsournal in the field of plastic surgery, the American Journal of Plastic and Reconstructive Surgery (PRS). PRS publishes only articles that have been subjected to rigorous quality testing by designated specialists in the field. Together with the participating authors from the Universities of Munich, Stanford, Vienna, Linz and Florida, we are pleased about this important milestone.
During the European Plastic Surgery Research Council 2017, held from 24th to 26th August in Bucharest, the department of Experimental Plastic Surgery of TU Munich presented the latest findings of their research on the skin-rejuvenating effects of Tomorrowlabs' HSF technology to an international audience of medical experts. Their lecture “Skin Rejuvenation Through Hif-1 Alpha Upregulation”, which demonstrated the study results of their scientific collaboration with Tomorrowlabs, was eventually awarded the prize for this year's best lecture of the internationally respected congress. The attending experts' keen interest in HSF technology as well as the appraisal by the EPSRC's jury prove the relevancy of the activation of cellular regeneration mechanisms to prevent and reverse signs of dermal aging. We congratulate all involved researchers on their success.
The close collaboration between Tomorrowlabs and leading university research facilities will be extended by a new research cooperation with the Department for Experimental Plastic Surgery of the Technical University of Munich and its Clinic Rechts der Isar. The department is focused on answering fundamental scientific questions and to efficiently implement their findings in a way that improves treatment options for patients. Considering the leading role of the department in the area of basic and clinical research, this cooperation will serve to explore novel applications of the cellular regeneration triggered by the revolutionary HSF technology.